Brief: Endo Provides Top-Line Results From Phase 2 Study Of Collagenase Clostridium Histolyticum (Cch) In Participants With Plantar Fibromatosis

Endo International

13/03/2023 20:17

March 13 (Reuters) - Endo International PLC  ENDPQ.PK :
    * ENDO PROVIDES TOP-LINE RESULTS FROM PHASE 2 STUDY OF
COLLAGENASE
CLOSTRIDIUM HISTOLYTICUM (CCH) IN PARTICIPANTS WITH PLANTAR
FIBROMATOSIS
    * ENDO INTERNATIONAL PLC - PRIMARY ENDPOINT WHEN ANALYZED
WITH
OVERALL STUDY POPULATION DID NOT MEET STATISTICAL SIGNIFICANCE
IN STUDY
    * ENDO INTERNATIONAL PLC - OVERALL CLINICAL STUDY POPULATION
MET
SOME KEY SECONDARY AND EXPLORATORY ENDPOINTS IN STUDY
    * ENDO INTERNATIONAL PLC - MOST ADVERSE EVENTS WERE RATED AS
MILD
TO MODERATE AND THERE WERE NO TREATMENT-RELATED SERIOUS ADVERSE
EVENTS IN STUDY

Source text for Eikon:  ID:nCNWZZWpfa 
Further company coverage:  ENDPQ.PK 

 ((Reuters.Briefs@thomsonreuters.com;))